Swissquote MEA facilitates pharma investments
Swissquote Bank Ltd., a global provider of online financial and trading services, has announced a new trading certificate, which enables investors to actively support companies in their fight against COVID-19.
Available to investors in the GCC through Swissquote MEA, Swissquote’s Pharma Opportunity Certificate allows its clients to invest in a comprehensive and diversified portfolio of the world’s leading pharmaceutical and biotech companies that are seeking solutions to put an end to the pandemic.
Dino Ibric, vice director at Swissquote MEA, said: “The year 2020 will undoubtedly go down in history as the year of COVID-19. “While most of us feel powerless in the face of all these events, our clients now have the opportunity to support the fight against the coronavirus by investing in companies that are researching the solutions for it.”